Search research articles
Contact Us
Filters
Showing results (131-140 of 153) with videos related to
Page
of 16
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
May 24, 2016
Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC)
Courtney D DiNardo, Sarah A Bannon, Mark Routbort, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 1, 2005
Chronic myelogenous leukemia
Susan O'Brien, Ellin Berman, Kapil Bhalla, et al.
Haematologica
|
March 23, 2023
Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)
Guillaume Richard-Carpentier, Caitlin R Rausch, Koji Sasaki, et al.
Blood
|
September 19, 2025
FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML
Reeja Raj, Samanta Catueno, Amber Gibson, et al.
American Journal of Hematology
|
March 31, 2012
Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: proceedings from the 6th International Post-ASH Symposium
Omar Abdel-Wahab, Animesh Pardanani, Olivier A Bernard, et al.
Blood Advances
|
November 2, 2022
Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AML
Ghayas C Issa, Aram Bidikian, Sangeetha Venugopal, et al.
American Journal of Hematology
|
September 4, 2023
Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants
Alex Bataller, Sanam Loghavi, Yoheved Gerstein, et al.
Cancer
|
August 9, 2025
Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3-tyrosine kinase domain mutations: Prognostic implications of NPM1 co-mutation
Sankalp Arora, Wei-Ying Jen, Musa Yilmaz, et al.
Journal of Hematology & Oncology
|
November 28, 2025
A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias
Jayastu Senapati, Marina Konopleva, Ghayas C Issa, et al.
Frontiers in Oncology
|
February 15, 2021
Next-Generation Sequencing of <i>DDX41</i> in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations
Sarah A Bannon, Mark J Routbort, Guillermo Montalban-Bravo, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 153) with videos related to
Sort By:
Page
of 16
Clinical Lymphoma, Myeloma & Leukemia
|
May 24, 2016
Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC)
Courtney D DiNardo, Sarah A Bannon, Mark Routbort, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 1, 2005
Chronic myelogenous leukemia
Susan O'Brien, Ellin Berman, Kapil Bhalla, et al.
Haematologica
|
March 23, 2023
Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)
Guillaume Richard-Carpentier, Caitlin R Rausch, Koji Sasaki, et al.
Blood
|
September 19, 2025
FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML
Reeja Raj, Samanta Catueno, Amber Gibson, et al.
American Journal of Hematology
|
March 31, 2012
Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: proceedings from the 6th International Post-ASH Symposium
Omar Abdel-Wahab, Animesh Pardanani, Olivier A Bernard, et al.
Blood Advances
|
November 2, 2022
Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AML
Ghayas C Issa, Aram Bidikian, Sangeetha Venugopal, et al.
American Journal of Hematology
|
September 4, 2023
Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants
Alex Bataller, Sanam Loghavi, Yoheved Gerstein, et al.
Cancer
|
August 9, 2025
Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3-tyrosine kinase domain mutations: Prognostic implications of NPM1 co-mutation
Sankalp Arora, Wei-Ying Jen, Musa Yilmaz, et al.
Journal of Hematology & Oncology
|
November 28, 2025
A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias
Jayastu Senapati, Marina Konopleva, Ghayas C Issa, et al.
Frontiers in Oncology
|
February 15, 2021
Next-Generation Sequencing of <i>DDX41</i> in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations
Sarah A Bannon, Mark J Routbort, Guillermo Montalban-Bravo, et al.
Page
of 16